ONABOTULINUMTOXINA SIGNIFICANTLY DECREASES URINARY INCONTINENCE AND PROVIDES TREATMENT BENEFIT IN PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER: A POOLED ANALYSIS OF TWO PHASE III, PLACEBO-CONTROLLED PIVOTAL TRIALS

Khullar V; Nitti V; Dmochowski R.; Sand P.; Chapple C.; Sievert K.; MacDiarmid S.; Radziszewski P.; Nardo C.; Zhou J.; Haag-Molkenteller C.; Herschorn S.

首页> 外文期刊>Neurourology and urodynamics. >ONABOTULINUMTOXINA SIGNIFICANTLY DECREASES URINARY INCONTINENCE AND PROVIDES TREATMENT BENEFIT IN PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER: A POOLED ANALYSIS OF TWO PHASE III, PLACEBO-CONTROLLED PIVOTAL TRIALS

【24h】

ONABOTULINUMTOXINA SIGNIFICANTLY DECREASES URINARY INCONTINENCE AND PROVIDES TREATMENT BENEFIT IN PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER: A POOLED ANALYSIS OF TWO PHASE III, PLACEBO-CONTROLLED PIVOTAL TRIALS

机译：原发性过度活动性膀胱疾病患者的尿失禁毒素明显降低尿尿排泄率，并提供治疗益处：对两个阶段III的局部分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neurourology and urodynamics.》 |2013年第6期|共1页
作者
Khullar V; Nitti V; Dmochowski R.; Sand P.; Chapple C.; Sievert K.; MacDiarmid S.; Radziszewski P.; Nardo C.; Zhou J.; Haag-Molkenteller C.; Herschorn S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. ONABOTULINUMTOXINA SIGNIFICANTLY DECREASES URINARY INCONTINENCE AND PROVIDES TREATMENT BENEFIT IN PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER: A POOLED ANALYSIS OF TWO PHASE III, PLACEBO-CONTROLLED PIVOTAL TRIALS [J] . Khullar V, Nitti V, Dmochowski R., Neurourology and urodynamics. . 2013,第6期

机译：原发性过度活动性膀胱疾病患者的尿失禁毒素明显降低尿尿排泄率，并提供治疗益处：对两个阶段III的局部分析
2. EARLY ONSET AND CONSISTENT RESPONSE OF ONABOTULINUMTOXINA TREATMENT WITH SIGNIFICANT RESOLUTION OF URINARY SYMPTOMS IN FEMALE OVERACTIVE BLADDER PATIENTS WITH URINARY INCONTINENCE IN A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 4 TRIAL [J] . Mccammon K., Gruenenfelder J., Lucente V. R., International urogynecology journal and pelvic floor dysfunction . 2017,第Suppla1期

机译：在多中心，随机安慰剂对照，第4期尿失禁中患有尿失禁患者的尿症状的泌尿症状治疗的早期发病和一致反应。
3. EARLY AND CONSISTENT IMPROVEMENTS IN URINARY SYMPTOMS AND QUALITY OF LIFE IN IDIOPATHIC OVERACTIVE BLADDER PATIENTS FOLLOWING REPEAT TREATMENT WITH ONABOTULINUMTOXINA: RESULTS OF A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 4 TRIAL [J] . McCammon K., Gousse A., Gruenenfelder J., Neurourology and urodynamics. . 2018,第Suppla5期

机译：早期和一致地改善特发性过度活性膀胱患者的泌尿症状和生活质量，伴有OnaboTulinumtoxina重复治疗：多中心，随机，安慰剂控制，第4期试验的结果
4. Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised double-blind placebo-controlled phase III studies [O] . V W Nitti, V Khullar, P Kerrebroeck, -1

机译：Mirabegron用于膀胱过度活动症的治疗：对三项随机双盲安慰剂对照的III期研究进行预先设定的合并疗效分析和合并安全性分析
5. OnabotulinumtoxinA (botulinum toxin type A) for the treatment of Japanese patients with overactive bladder and urinary incontinence: Results of single‐dose treatment from a phase III, randomized, double‐blind, placebo‐controlled trial (interim analysis) [O] . Osamu Yokoyama, Masashi Honda, Tomonori Yamanishi, 2020

机译：OnaboTulinumtoxina（肉毒杆菌毒素A型）用于治疗日本过度活性膀胱和尿失禁的患者：单剂量治疗的结果来自III期，随机，双盲，安慰剂对照试验（中期分析）

ONABOTULINUMTOXINA SIGNIFICANTLY DECREASES URINARY INCONTINENCE AND PROVIDES TREATMENT BENEFIT IN PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER: A POOLED ANALYSIS OF TWO PHASE III, PLACEBO-CONTROLLED PIVOTAL TRIALS

著录项

相似文献

相关主题

期刊订阅